Definitive Contract W81XWH17C0027

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Air Force Research Laboratory (AFRL) to Epibone, Inc., a corporate, for-profit organization. The $1,249,628.00 firm-fixed-price contract is focused on validating Epibone's EB-CMF regenerative bone grafts for use in craniofacial surgery, specifically for the maxilla. The research and development work is aimed at providing innovative medical solutions for military personnel suffering from severe bone trauma....

<p>This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Epibone, Inc., a for-profit organization, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of an &quot;Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler&quot; and has a Firm Fixed Price of $999,921.26. The contract was awarded on August 27, 2018, with a completion date of December 26, 2021. The place of performance is Brooklyn, NY 11226, USA.</p>

The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25M Small Business Innovation Research (SBIR) Program Phase II contract to Epibone, Inc., a Jersey City-based regenerative medicine company specializing in advanced tissue engineering and personalized bone reconstruction. Issued on August 28, 2025, with completion targeted for June 1, 2027, this firm fixed-price purchase order is designated as a total small business set-aside. The contract supports development of EB-OC, a next-generation...

This federal contract award, with an ID of FA864924P0954, is for the &quot;EPIBONE: SOLUTION TO PROVIDE BONE RECONSTRUCTION DUE TO BATTLEFIELD INJURY&quot; project, awarded to Epibone, Inc., a small business located in Jersey City, New Jersey. The $74,871 firm fixed-price purchase order was awarded on August 16, 2024 under the Small Business Innovation Research (SBIR) Program Phase I by the Air Force Research Laboratory (AFRL), a defense-oriented federal agency. The contract aims to develop...

<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of the Army Materiel Command Research Development and Engineering Command to Biodesigns, Inc., a for-profit Subchapter S corporation. The $148,505.30 firm fixed-price contract is for research under the SBIR program. The contract has a completion date of October 31, 2020 and was awarded on September 19, 2019. The place of performance is Thousand Oaks, CA.</p>

This is a $149,035.04 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Premitec Inc., a for-profit organization. The contract was awarded on November 26, 2013, with an ultimate completion date of October 5, 2015. It is a firm-fixed-price definitive contract, which means the agreed-upon price for the contracted work will not change. The SBIR program is designed to support research and development of innovative technologies by small...

<p>This contract was awarded by the Department of the Army Medical Command to Bio1 Systems, Inc., a woman-owned small business, for a SBIR Program Phase I research effort. The contract was awarded on August 15, 2017 with a firm fixed price of $150,000.00 and a completion date of March 14, 2018. The contract was set aside for small businesses.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Sophia Speira LLC, a small business located in Durham, North Carolina. The contract has a ceiling value of $124,984.80 and a completion date of April 18, 2017. This definitive, firm-fixed-price contract is part of the SBIR H161-003-0099 program, which is focused on research and development. As a Phase I SBIR award, this contract supports the initial feasibility study or...

This is a $1,094,682.00 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Epigen Biosciences Inc., a small business based in San Diego, California. The contract is for the research and development of small molecule compounds, with a focus on potential therapeutic applications in areas such as stroke, liver diseases, neurodegenerative disorders, and neuropathic conditions. Epigen Biosciences has received prior grant funding from various National Institutes of Health...

This is a $140,910.00 firm-fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Sim-Vivo LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract supports a Phase I SBIR effort, indicated by the &quot;SBIR DHP PHASE I PROPOSAL H161-011-0101&quot; description. The contract was awarded on September 30, 2016 with a completion date of July 29, 2017. The contract has a &quot;Total Small Business&quot; set-aside designation.